Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RVX-100 in IBS-D
NCT01076699Phase 2Suspended
- Sponsor
- Revogenex Ltd.
- Start
- Mar 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RVX-100 in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Revogenex Ltd.. Started Mar 2010; status: suspended.
02
Drugs
RVX-100
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01076699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01076699.